LetsGetChecked is moving into genomics with the acquisition of the genetic testing technology provider, allowing Lilly Ventures Asia and Jiangsu Simcere to exit.

At-home diagnostic test provider LetsGetChecked agreed to acquire US-based genetic testing technology developer Veritas Genetics on Tuesday for an undisclosed sum, providing exits for pharmaceutical firms Eli Lilly and Jiangsu Simcere Pharmaceutical.

Spun out of Harvard University in 2014, Veritas offer sgenome and exome based genetic tests used to detect hereditary illnesses such as cancer and reproductive health conditions. LetsGetChecked is also buying Veritas Intercontinental which was spun off in 2018 to focus on markets outside the US.

The deal…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Fernando Moncada Rivera

Fernando Moncada Rivera is a reporter at Global Corporate Venturing and also host of the CVC Unplugged podcast.
Email LinkedIn